Paul Andrew Moore, Chief Scientific Officer at Zymeworks Inc. (ZYME), sold 20,110 shares at $25.10 ($505K) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Open-market sale of $505k ZYME by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.10 | 9,289 | $233K | 46.2% |
| 2 | $25.10 | 10,821 | $272K | 53.8% |
| Total | $25.10 avg | 20,110 | $505K | 100% |
| Filing → |
| ZYME | SELL | 2024-01-08 | $106K | — | Filing → |